Old Web
English
Sign In
Acemap
>
authorDetail
>
M. den Hollander
M. den Hollander
Leiden University Medical Center
Pharmacology
Sunitinib
Pharmacokinetics
Medicine
Cancer
3
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
2016
Journal of Clinical Oncology
Paul Hamberg
N. Steeghs
W. J. Loos
D. van der Biessen
M. den Hollander
Metin Tascilar
J. Verweij
Hans Gelderblom
Stefan Sleijfer
Show All
Source
Cite
Save
Citations (1)
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
2014
Cancer Chemotherapy and Pharmacology
D. de Wit
Hans Gelderblom
Alex Sparreboom
J. den Hartigh
M. den Hollander
Jacqueline M. C. König-Quartel
Trees J. Hessing
H.-J. Guchelaar
N. P. van Erp
Show All
Source
Cite
Save
Citations (19)
1